Anne Serdakowski London

Medicine · Health Sciences

7h-index473citations20works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Mechanisms and Therapy(7), Cancer Cells and Metastasis(4), Microtubule and mitosis dynamics(4), Protein purification and stability(4), Monoclonal and Polyclonal Antibodies Research(3)

Publications20 total

Supplementary Figure Legends from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Data from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Figures 1 through 7 from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Figure Legends from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Material and Methods from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Tables 1 through 11 from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Data from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Figures 1 through 7 from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Tables 1 through 11 from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Supplementary Material and Methods from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
2023Open Access
Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers
Cancer Discovery·2017· 52 citedOpen Access
Abstract 2974: Targeting cadherin-6 (CDH6) with an antibody-drug conjugate for the treatment of ovarian and renal cancer
Cancer Research·2016· 1 cited
Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies
Oncogene·2016· 86 citedOpen Access
A novel method to determine residual detergent in biological samples post endotoxin reduction treatment and evaluation of strategies for subsequent detergent removal
International Immunopharmacology·2015· 11 cited
Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung
Cell Reports·2014· 253 citedOpen Access
Application of coupled affinity-sizing chromatography for the detection of proteolyzed HSA-tagged proteins
Protein Expression and Purification·2014· 2 cited
Gel filtration chromatography as a method for removing bacterial endotoxin from antibody preparations
Biotechnology Progress·2014· 21 cited
Corrigendum to: <i>Endotoxin removal and prevention for pre‐clinical biologics production</i>
Biotechnology Journal·2013
Coupled affinity and sizing chromatography: A novel in-process analytical tool to measure titer and trend Fc-protein aggregation
Journal of Immunological Methods·2013· 13 cited
Endotoxin removal and prevention for pre‐clinical biologics production
Biotechnology Journal·2012· 34 citedOpen Access

Frequent Co-authors

William R. Tschantz(14), Seth A. Ettenberg(12), Carl Uli Bialucha(12), Parmita Saxena(12), Yeonju Shim(12), Rebecca Mosher(12), Lance Ostrom(12), Tiancen Hu(12), Sanela Bilic(12), Ivana Liric Rajlic(12), Vladimı́r Čápka(12), Meghan Flaherty(12), Keith G. Mansfield(12), Markus Kurz(12), Duc T. Nguyen(12), Aaron Bourret(12), Matthew J. Meyer(12), Nicholas C. Yoder(12), Kalli C. Catcott(12), Molly A. McShea(12)